199 Bay St, Suite 5300, Commerce Court West, Toronto, ON
Year called to bar: 2007 (QC); 2019 (ON)
Kim Le is a partner in the Mergers & Acquisitions and Private Equity Groups. Her practice focuses on corporate and commercial law, including public and private mergers and acquisitions. Kim has extensive experience working with private equity funds, private equity portfolio companies and multinational corporations, as well as advising on all aspects of cross-border private equity. Kim also works on matters involving venture capital investments, joint ventures and partnerships, complex shareholder agreements, and insolvency and restructuring. She represents and acts as a trusted advisor on general corporate and commercial matters for clients across the technology, food and beverage, mining and engineering industries. Kim is a member of the firm’s Diversity & Inclusion Committee and of the Québec Bar and the Ontario Bar. She is also a member of the Next Generation Committee of the Jewish General Hospital Foundation. Kim has received the 2020 Lexpert Rising Stars: Leading Lawyers Under 40 award.
Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with an emphasis on the injectable market, completed its acquisition of Omega Laboratories Limited, a market leading specialty pharmaceutical company based in Montreal, for approximately US$85.3 million (C$95 million) in cash. The combination of Sagent and Omega creates a premier generic injectable company with a robust product portfolio, deep development pipeline and strong global presence.